Lantheus Holdings (LNTH) Intangibles (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Intangibles of $936.5 million for Q1 2026, up 509.1% year-over-year from $153.7 million in Q1 2025, and up 29.56% quarter-over-quarter from $722.8 million in Q4 2025.
Lantheus Holdings (LNTH) Intangibles (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Intangibles for 13 consecutive years, with $936.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles rose 509.1% year-over-year to $936.5 million; the TTM figure through Mar 2026 stood at $936.5 million (up 509.1% YoY), while the FY2025 annual figure was $722.8 million, up 346.82% from the prior year.
- Intangibles rose to $936.5 million in Q1 2026 per LNTH's latest filing, from $722.8 million in the prior quarter.
- Across five years, Intangibles topped out at $936.5 million in Q3 2025 and bottomed at $40.3 million in Q2 2024.
- Historically, Intangibles has averaged $335.0 million across 5 years, with a median of $221.0 million in 2023.
- Annual changes were most pronounced in 2024 — Intangibles plunged 81.77% — and 2025, when it jumped 793.17%.
- Lantheus Holdings' Intangibles stood at $315.3 million in 2022, then slumped by 51.79% to $152.0 million in 2023, then climbed by 6.43% to $161.8 million in 2024, then soared by 346.82% to $722.8 million in 2025, then gained by 29.56% to $936.5 million in 2026.
- Business Quant data shows LNTH's Intangibles at $936.5 million in Q1 2026, $722.8 million in Q4 2025, and $936.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 936.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 936.40 Mn |
| Mar 31, 2026 | 936.46 Mn |
| Dec 31, 2025 | 722.78 Mn |
| Sep 30, 2025 | 936.46 Mn |
| Jun 30, 2025 | 359.95 Mn |
| Mar 31, 2025 | 153.75 Mn |
| Dec 31, 2024 | 161.76 Mn |
| Sep 30, 2024 | 173.61 Mn |
| Jun 30, 2024 | 40.30 Mn |
| Mar 31, 2024 | 142.05 Mn |
| Dec 31, 2023 | 151.99 Mn |
| Sep 30, 2023 | 163.29 Mn |
| Jun 30, 2023 | 221.00 Mn |
| Mar 31, 2023 | 219.86 Mn |
| Dec 31, 2022 | 315.29 Mn |
| Sep 30, 2022 | 323.59 Mn |
| Jun 30, 2022 | 331.90 Mn |
| Mar 31, 2022 | 340.20 Mn |
| Dec 31, 2021 | 348.51 Mn |
| Sep 30, 2021 | 356.88 Mn |